Invention Grant
US07718166B2 Immunotherapy for prostate cancer using recombinant bacille Calmette-Guerin expressing prostate specific antigens
有权
使用重组杆菌Calmette-Guerin表达前列腺特异性抗原的前列腺癌的免疫治疗
- Patent Title: Immunotherapy for prostate cancer using recombinant bacille Calmette-Guerin expressing prostate specific antigens
- Patent Title (中): 使用重组杆菌Calmette-Guerin表达前列腺特异性抗原的前列腺癌的免疫治疗
-
Application No.: US10378449Application Date: 2003-03-03
-
Publication No.: US07718166B2Publication Date: 2010-05-18
- Inventor: Jan Geliebter
- Applicant: Jan Geliebter
- Applicant Address: US NY Scarsdale
- Assignee: Applied Immune Technologies
- Current Assignee: Applied Immune Technologies
- Current Assignee Address: US NY Scarsdale
- Agency: Kenyon & Kenyon LLP
- Main IPC: C12N1/21
- IPC: C12N1/21
Abstract:
The present invention relates to the treatment of prostate cancer. Methods and compositions comprising recombinant BCG are provided for eliciting potent immune responses against prostate specific antigens that are effective for treatment of prostate cancer and metastatic disease.
Public/Granted literature
Information query
IPC分类:
